Soaring Demand Drives Peptide Based Gastrointestinal Disorders Therapeutics Mark

Posted by Arslan on December 10th, 2018

Peptide is a biologically, naturally or artificially constituted form of amino acid monomers. Peptides can be utilized for treating various gastrointestinal disorders that mostly effect parts of the digestive system such as the gastrointestinal tract, large intestine, small intestine, stomach, esophagus, and rectum. Peptides are considered as an effective therapeutic agent for treating gastrointestinal diseases. Owing to their impressive preclinical results, an array of new peptide based gastrointestinal disorder therapeutics are expected to enter the market soon.

Get Free Sample Report here @ https://www.factmr.com/connectus/sample?flag=S&rep_id=190

Drug makers are increasingly partnering with medical research centers and institutes to develop more effective peptide drugs. This, in turn, is projected to make a positively impact on the growth of the global peptide based gastrointestinal disorders therapeutics market in the near future.  A recent study conducted by Fact.MR reveals that the global market for peptide based gastrointestinal disorders therapeutics is poised to exhibit a strong CAGR during the forecast period (2017-2022), to reach a valuation in excess of US$ 600 Mn. Growing occurrence of metabolic disorders and gastrointestinal ailments related to the digestive system is compelling physicians to utilize novel therapeutic drugs that are more efficient than the traditional ones. In addition, incessant structural improvements in peptide synthesis coupled with development of high-throughput approaches and hybrid mixing of solid and liquid synthesis is partly responsible for the exciting preclinical results shown by new peptide drugs for treating a number of gastrointestinal diseases. Drug makers are also emphasising on enhancing peptide properties, such as stability and half-life to overcome few of the limitations of peptides. In recent years, a lot of progress has been made in developing efficacious peptide therapeutics. Nonetheless, the high complexity of peptides remain a major challenge for manufacturers and hence dampening the surging spirit of the market to a certain extent.

North America to Lead the Global Peptide Based Gastrointestinal Disorders Therapeutics Market

In terms of revenue, North America is expected to hold the dominant share of the global peptide based gastrointestinal disorders therapeutics market in 2017 and beyond. Factors such growing patient awareness and rapid adoption of peptide based therapeutics for treating various diseases are expected to support the growth of the market in the region.  During the forecast period, the market in the region is projected to surge at a robust CAGR of 13.9%.

On the basis of drugs, the linaclotide segment is expected to retain its dominant position over 2022. Currently, the segment accounts for more than two-third share of the market in terms of revenue. Towards the end of the forecast period, the linaclotide segment is estimated to reach a market valuation in excess of US$ 466 Mn.

Competition Tracking

Shire plc, Ironwood Pharmaceuticals, Inc., Astellas Pharma Inc., Allergan plc, Accredo Health Group, Inc., are the key market players profiled in the Fact.MR’s report. A majority of these companies are channelizing investment in further expansion of their product portfolio. This, in turn, is anticipated to result in introduction of more efficacious peptide based therapeutic drugs for curing gastrointestinal ailments.

Table of Content:

  1. Global Peptide Based Gastrointestinal Disorders Therapeutics Market - Executive Summary
  2. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Overview
    2.1. Introduction
         2.1.1. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Taxonomy
         2.1.2. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Definition
    2.2. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size (US$ Mn) and Forecast, 2012-2022
           2.2.1. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Y-o-Y Growth
    2.3. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Dynamics
    2.4. Regulations
    2.5. Supply Chain
    2.6. Cost Structure
    2.7. Average Pricing Analysis 
    2.8. Epidemiology
    2.9. Key Participants Market Presence (Intensity Map) By Region
  3. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Analysis and Forecast By Drug 
    3.1. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast By Drug, 2012-2022
         3.1.1. Teduglutide Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast, 2012-2022
                  3.1.1.1. Revenue (US$ Mn) Comparison, By Region
                    3.1.1.2. Market Share Comparison, By Region

Related Articles

Peptide Based Gastrointestinal Disorders Therapeutics Market Expectations
Drug makers are increasingly partnering with medical research centers and institutes to develop more effective peptide drugs. This, in turn, is projected to make a positively impact on the growth of t...

Global Peptide Based Gastrointestinal Disorders Therapeutics Market Expectations
Pharmaceutical companies are increasingly collaborating with medical institutes and research centers in order to ramp up R&D pipelines of peptide drugs. This is expected to influence the growth of...

Also See: Therapeutics Market, Peptide Based, Global Peptide, Gastrointestinal Disorders, Therapeutics, Peptide, Market
Link To Directory
Top Searches - Trending Searches - New Articles - Top Articles - Trending Articles - Featured Articles - Top Members

Copyright 2019 Uberant.com
502,249 total articles and counting.